Sprissler, Ryan http://orcid.org/0000-0001-9250-2320
Hammer, Michael
Labiner, David
Joshi, Neil
Alan, Albert
Weinand, Martin
Funding for this research was provided by:
NIH (RO1MH065151)
Article History
Received: 18 September 2022
Accepted: 26 October 2023
First Online: 2 January 2024
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the University of Arizona Institutional Review Board and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.IRB# 1401194084, The University of Arizona. Informed consent to participate in the study was obtained from all participants and full documentation is able to be provided upon request.
: Author M.W. personally obtained University of Arizona IRB-approved consent for all subjects. All patients we informed during the research consent process that their results, including demographic data, will be aggregated, published and available to the general public in the scientific literature, including through the <i>Pub Med</i> website during explanation of Subject Consent, Page 7, lines 245 & 246<u>:</u> “Will I hear back on any results that directly impact me?—The results of our research at UA will be available in the public domain.”
: The authors declare that they have no competing interests. Author Dr. Weinand has been assigned the following patent application by the University of Arizona (patent ID# UA23-142) titled, “METHODS FOR THE PROGNOSIS AND TREATMENT OF TEMPORAL LOBE EPILEPSY.” for work relating to the research described in this manuscript. Dr. Weinand has received no financial compensation for the above assigned patent.